Drug
Ocrevus Zunovo NDC Codes
Ocrevus Zunovo is listed in the FDA NDC Directory as 1 finished product from 1 labeler.
Overview
Active ingredients: Ocrelizumab, Hyaluronidase (Human recombinant). Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Generic name
- Ocrelizumab and hyaluronidase
- Active ingredients
- Ocrelizumab, Hyaluronidase (Human recombinant)
- Labelers
- Genentech, Inc.
- Strengths
- Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Drug classes (FDA established)
- CD20-directed Cytolytic Antibody, Endoglycosidase
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Ocrevus Zunovoocrelizumab and hyaluronidase | Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-554 | 50242-0554-0150242-0554-86 | — |
Ocrevus Zunovo: common questions
- What is the NDC for Ocrevus Zunovo?
- Ocrevus Zunovo has 1 product NDC, one for each strength, dosage form and labeler; each product NDC then has one package NDC per package size. Pick the row for your product above to see its package NDCs.
- Is there a J-code for Ocrevus Zunovo?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.